Susan Schneider, Director, Discovery Medicine, Gsk Ophthalmology, Will Give Featured Presentation at Gtc’s 3rd Ocular Diseases & Drug Discovery Conference, Boston, Ma, May 26-27 2011
Susan Schneider, Ph.D., Director, Discovery Medicine, GSK Ophthalmology will present on Systemic Administration of an Anti-Amyloid Beta Monoclonal Antibody Interferes with the Ocular Pathology of a Mouse Model of Age-Related Macular Degeneration at GTC’s 3rd Ocular Diseases & Drug Discovery Conference on May 26-27, 2011 in Boston, MA.
View full press release